Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Aoyama, Kei ^a   Kamio, Takako ^a   Ohchi, Tetsuya ^a   Nishizawa, Masako ^a   Kameoka, Shingo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Fluorescence imaging; Indocyanine green; Sentinel lymph node biopsy

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BRAIN METASTASIS; BREAST AREOLA; CANCER DIAGNOSIS; CANCER PATIENT; FEMALE; FLUORESCENCE IMAGING; HUMAN; INTRADUCTAL CARCINOMA; LIGHT EMITTING DIODE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; FLUORESCENCE; LUNG CARCINOMA; LYMPH NODE; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLORING AGENTS; FEMALE; FLUORESCENCE; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 82455162803     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-157     Document Type: Article

References (39)

1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Eng J Med 2003, 349:546-553.
2. Noguchi M. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in brast cancer patients. J Surg Oncol 2001, 76:144-156. 10.1002/1096-9098(200102)76:2<144::AID-JSO1028>3.0.CO;2-H, 11223844.
3. Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A, Ebihara S. Correlation between concordance of tracers, order of harvest, and presence of metastases in sentinel lymph nodes with breast cancer. Ann Surg Oncol 2005, 12:1-7. 10.1245/ASO.2005.10.907, 15827768.
4. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99 m sulfur colloid. J Am Coll Surg 2002, 195:467-475. 10.1016/S1072-7515(02)01312-1, 12375751.
5. Imoto S, Wada N, Murakami K, Hasebe T, Ochiai A, Ebihara S. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Jpn J Clin Oncol 2004, 34:452-456. 10.1093/jjco/hyh077, 15371462.
6. Tuttle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004, 70:407-413.
7. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, Koyama H. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 2001, 76:95-99. 10.1002/1096-9098(200102)76:2<95::AID-JSO1018>3.0.CO;2-D, 11223834.
8. Tefra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001, 233:51-59. 10.1097/00000658-200101000-00009, 1421166, 11141225.
9. Derossis AM, Fey J, Yeung H, Yeh SDJ, Heerdt AS, Petrek J, VanZee KJ, Montgomery LL, Borgen PI, Cody HS. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001, 193:473-478. 10.1016/S1072-7515(01)01038-9, 11708502.
10. Krag DN, Weaver OJ, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993, 2:335-340. 10.1016/0960-7404(93)90064-6, 8130940.
11. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P, Whitworth P, Foster R, Dowlatshahi K. The sentinel node in breast cancer-A multicenter validation study. N Engl J Med 1998, 339:941-946. 10.1056/NEJM199810013391401, 9753708.
12. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997, 15:2345-2350.
13. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-401. 10.1097/00000658-199409000-00015, 1234400, 8092905.
14. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanin green dye in breast cancer patients. Jpn J Clin Oncol 1999, 29:604-607. 10.1093/jjco/29.12.604, 10721942.
15. Cox CE, Salud CJ, Cantor A, Bass SS, Peltz ES, Ebert MD, Nguyen K, Reintgen DS. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001, 193:593-600. 10.1016/S1072-7515(01)01086-9, 11768674.
16. Classe JM, Curtet C, Campion L, Rousseau C, Fiche M, Sagan C, Resche I, Pioud R, Andrieux N, Dravet F. Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol 2003, 29:426-433. 10.1016/S0748-7983(03)00052-0, 12798745.
17. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 2005, 12:211-215. 10.2325/jbcs.12.211, 16110291.
18. Ogasawara Y, Ikeda H, Takahashi M, Kawasaki K, Doihara H. Evaluation of breast lymphatic pathway with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg 2008, 32:1924-1929. 10.1007/s00268-008-9519-7, 18330628.
19. Bass SS, Cox CE, Salud CJ, Lyman GH, McCann C, Dupont E, Berman C, Reintgen DS. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg 2011, 192:9-16.
20. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006, 98:599-609. 10.1093/jnci/djj158, 16670385.
21. Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL, Noyes RD, Beitsch PD. Prerandomization surgical training for the national surgical adjuvant breast and bowel project(NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005, 241:48-54. 1356845, 15621990.
22. White RL, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Ann Surg 2004, 70:420-424.
23. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 2001, 25:819-822. 10.1007/s00268-001-0011-x, 11376421.
24. Bergkvist L, Frisell J. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2001, 88:1644-1648. 10.1046/j.0007-1323.2001.01948.x, 11736980.
25. Martin RC, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown M, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, McMasters KM. Practical guidelines for optimal gammaprobe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery 2000, 128:139-144. 10.1067/msy.2000.108064, 10922983.
26. Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K. A multicenter validation study of sentinel lymph node biopsy by the Japanese breast cancer society. Breast Cancer Res Treat 2000, 63:31-40. 10.1023/A:1006428105579, 11079157.
27. Martin RC, Fey J, Yeung H, Borgen PI, Cody HS. Highest isotope count dose not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 2001, 8:592-597. 10.1007/s10434-001-0592-5, 11508621.
28. Quan ML, McCready D, Temple WJ, McKinnon JG. Biopsy of lymphatic metastases in breast cancer: lessons learned from sentinel node biopsy. Ann Surg Oncol 2002, 9:467-471. 10.1007/BF02557270, 12052758.
29. Camp ER, Cendan JC, Feeor R, Lind DS, Wilkinson E, Copeland EM. The hottest sentinel lymph node is not always the positive node. Am Surg 2004, 70:475-478.
30. Motomura K, Komoike Y, Hasegawa Y, Kasugai T, Inaji H, Noguchi S, Koyama H. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients. J Surg Oncol 2003, 82:91-96. 10.1002/jso.10200, 12561063.
31. Bauser TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, Bedrosian I, Fraker DL, Bauser TL, Czerniecki BJ. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002, 9:169-176. 10.1007/BF02557370, 11888875.
32. Chagpar A, Martin III RC, Chao C, Wong SL, Edwards MJ, Tuttle T, McMasters KM. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004, 139:614-618. 10.1001/archsurg.139.6.614, 15197087.
33. Gray RJ, Pockaj BA. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping. Am J Surg 2004, 188:423-425. 10.1016/j.amjsurg.2004.06.018, 15474440.
34. Noguchi M, Inokuchi M, Zen Y. Complement of peritumonal and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol 2009, 100:100-105. 10.1002/jso.21308, 19479943.
35. Gawlick U, Mone MC, Nelson ED, Hansen HJ, Nelson EW. Success in sentinel lymph node procedures in obese patients with breast cancer. Am J Surg 2010, 200:707-711. 10.1016/j.amjsurg.2010.07.031, 21146008.
36. Johnson MT, Guidroz JA, Smith BJ, Graham MM, Scott-Conner CEH, Sugg SL, Weigel RJ. A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Surgery 2009, 146:671-677. 10.1016/j.surg.2009.06.025, 19789026.
37. Cox CE, Dupont E, Whitehead GF, Ebert MD, Nguyen K, Peltz ES, Peckham D, Cantor A, Reintgen DS. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002, 8:88-91. 10.1046/j.1524-4741.2002.08203.x, 11896753.
38. Derossis AM, Fey JV, Cody HS, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg 2003, 197:896-901. 10.1016/j.jamcollsurg.2003.08.005, 14644276.
39. Hughes M, Goffman TG, Perry RR, Laronga C. Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg 2004, 187:52-57. 10.1016/j.amjsurg.2003.04.004, 14706586.